Try our Advanced Search for more refined results
Health - March, 2012
301 articles
- $100M CIGNA Sex Bias Suit Shut Down
- Blue Cross Michigan Dodges City's Price-Fixing Suit
- Calif. High Court To Mull Employer Arbitration Deals Again
- Judge Keeps Investor Suits Over Acadia-PHC Merger Alive
- Doctors Beg CMS For Relief From 'Storm' Of Regulations
- W.Va. Hospital Cos. Pay $2.25M Over FCA Medicaid Claims
- Detroit Clinic Owner Admits To $5.4M Medicare Fraud
- Amerigroup Will Pay $4.5M To Settle Sales Reps' OT Action
- Case Study: Hermelin V. KV Pharmaceutical
- Questioning The Enforcement Of Arbitration Provisions
- Medicare's Pay For Performance Didn't Cut Mortality: Study
- House Passes $3.5T Ryan Budget Plan
- Insurers Can't Shake General Refractories' Coverage Suit
- 3rd Circ. Boots Judge From West Penn Antitrust Case
- Ex-Temple Med School Official Gets 7 Years For Health Fraud
- Court Rules NY Medicaid Boost For Psychiatry Ended In '07
- Pharmacy Groups Sue Express Scripts, Medco Over $29B Deal
- FTC Says Pharmacy Antitrust Amnesty Will Hurt Competition
- Searching For Patent Drafting Pointers In Prometheus
- The Evolution Of Medicare ACOs
- States' Medicaid Coercion Argument Sways Some Justices
- 5 Hit With New Indictment In $14.5M Medicare Scam Case
- Judge Limits Claims In Quest Ageism Suit To NJ Workers
- Health Co. To Cough Up $7M To End Medicaid Fraud Claims
- $29B Express Scripts, Medco Merger Could Come Next Week
- Justices Divided On Power To Scrap Entire Health Care Law
- NY Dems Slam GOP For Holding Out Against Health Exchange
- Fla. Appeals Court Affirms $3.4M Award To Smoker's Widow
- FTC Orders ProMedica To Sell Ohio Hospital
- 11th Circ. Keeps Door Shut On Cigna Antitrust Claims
- FTC Says Mo. Bill Would Limit Pain Treatment Choices
- 3rd Circ. Seeks Ruling On Whether Health Dues Are Plan Assets
- Ratting Out The Competition: New DOJ Strategies
- Must-Have Performance Metrics For Law Departments
- High Court's Take On Health Market Key To ACA Decision
- Health Reform Poses Few New Litigation Risks, GAO Finds
- HIPAA Privacy Updates Head To White House For Final Review
- $45M Winning Bid For Bankrupt NJ Hospital OK'd
- Lawmakers Vow Health Law Repeal If High Court Lets It Stand
- TriWest Seeks To Wrest $20.5B DOD Contract From Rival
- $133B NY Budget To Boost Energy, Infrastructure Projects
- Humana Divests To Win DOJ Blessing For $150M Arcadian Buy
- Rapiscan Can't Shake X-Ray Distributor's $30M Contract Suit
- Costs Don't Have To Affect Medicaid Rates: Calif. Court
- Insurers V. Out-Of-Network Providers: An Ongoing Battle
- Hospital Group Says FCA Suit Is Light On False Claims
- 9th Circ. Keeps Calif. Medicaid Cuts Blocked
- High Court Health Reform Battle Focuses On Tax Law
- House Dems' Budget To Reinforce PPACA Medicare Coverage
- Chamber, Defense Attys Tell Supreme Court FLSA Suit Is Moot
- 11th Circ. Maintains Block On Aetna Antitrust Claims
- Court Finds For Attransco In $10M Asbestos Appeal
- $50M Worth Of Tobacco Appeals Won't Get High Court Hearing
- Protecting Patient Info In The Age Of Social Media
- A 'Shocking' Claim Of Design Defect
- Pharmaceutical Industry Trending Toward Self-Regulation
- Health Insurance Exchange Not In NY GOP's Senate Budget
- Medco Settles CalPERS Bribery Suit For $3M
- Philly Nurses Indicted In $14.3M Medicare Fraud Scheme
- States Enact Early Health Reforms As Tougher Terms Loom
- FTC Seeks High Court Scrutiny Of Ga. Hospital Merger
- Health Care Reform Faces Ultimate Test In High Court
- Fla. Oncologists Sued Over Alleged $3.5M Medicare Fraud
- Lawmaker Says Bill Would Shrink Medicare Part C Costs
- Cryobank Denied Coverage In Fighting Investor Fraud Claims
- LifeWatch Pays $18.5M To Settle DOJ Medicare Claims Suits
- Tax Benefits Biased Under DOMA, Calif. Employees Say
- PPACA: A Pandora's Box For The Health Care Industry
- DC Circ. Renews CVS Pharmacies' Controlled Drug Sales Ban
- Genzyme Tops Cobrek In Kidney Drug Patent Fight
- Judge Trims Mich. Nurses' Wage-Fixing Action
- UK Court Invalidates AstraZeneca's Seroquel XR Patent
- HHS Calls Out Two Insurers For 'Unreasonable' Rate Hikes
- Judge Trims Expert Testimony In Novartis Bone Drug Suit
- After Prometheus Loss, High Court Eyes Cancer Gene Patent
- High Court Asked To Reinstate $26M Merck Vioxx Judgment
- More Inspiration From The Courts On Commercial Speech
- Fed. Circ. Axes Sanofi IP Claims Over Genentech Cancer Drugs
- House Votes To Nix Medicare Cost-Cutting Board
- Husch Blackwell Picks Up Duane Morris Patent Pro
- Wash. Takes Emergency Contraceptives Ruling To 9th Circ.
- Sessions Blocks Vote To Air High Court Health Law Debate
- Cos. Must ID Supervisors Before Union Campaigns, Attys Say
- Stryker's Wingspan Stent May Raise Stroke Risk, FDA Says
- Community Health Escapes Tenet Medicare Billing Suit
- Justices' Questions May Signal Health Mandate's Fate
- Report Finds Medicaid Audit System Needs Overhaul
- Pharmacies Targeted In Probe Of Gray-Market Drug Sales
- Stakeholders To Weigh In On Making More Drugs OTC
- GOP Zeroes In On Agency Implementing Health Care Law
- Insurers Stuck In Asbestos Duty-To-Defend Suit
- Judge Tosses Calif. County's Vioxx Class Action
- Rising Star: Paul Weiss' Jacqui Rubin
- Fewer Life Sciences Co. Investor Suits Lodged In 2011
- DC Circ. Says ViroPharma Can't Sue FDA Over Generics Ruling
- GSK, J&J Back New $198.5M Incubator Fund
- Expanding The 'Quick Look' Framework
- Skowron To Pay Morgan Stanley $10.2M For Stock Dump
- Roche Urges Illumina Shareholders To Spur $6B Merger
- Canada Places Cancer Warnings On Merck And GSK Drugs
- Ala. Can't Claim Sovereign Immunity In Hiring Suit: 11th Circ.
- Battle Rages Over Home Health Workers' FLSA Status
- High Court Eyes Power of Federal Funds in Health Law Row
- Bill Nixing Health Law's Medicare Board Advances
- Dissecting Mayo V. Prometheus
- Waxman Pressures FTC On $29B Express Scripts, Medco Deal
- Rising Star: King & Spalding's Marian Lee
- TriWest Loses $20B Military Health Deal After Fraud Fine
- Pfizer To Pay Oregon $3.3M To End Zyvox Marketing Suit
- GOP's Budget Pushes For Medicare Voucher System
- Judge Tainted $60M Trademark Row, NuVasive Tells 9th Circ.
- OTC Drugmaker Says BioZone Breached Cold Meds Contract
- Case Study: Abbott Point Of Care V. Epocal
- Prometheus Blood Test Unpatentable, High Court Rules
- GSK Asks High Court To Buck DOL On Sales Reps' OT Status
- Mylan, Apotex Secure FDA Approval For Generic Boniva
- Rising Stars: Hunton & Williams' Colleen Heisey
- FDA Recalls Brilliant Blue G After Eye Infection Reports
- Mercer Consultant Pleads Guilty To Insider Trading
- Convicted NY Hospital Fraud Plotters Say DOJ Hid Witness
- Tax Code Ruling Could Leave Health Reform Law In Limbo
- Activists Push NY Senate On Health Insurance Exchange
- FTC Urged To Probe Merck, Sanofi Vaccine Bundling
- Challenging Providers: A Health Plan Flexes Its Muscle
- Judge Clears Feds For Withholding Generic Vancocin Docs
- Presenting ... A Fresh Interpretation Of Old Policy
- Blue Cross ERISA Class Rebuffed By High Court
- Covidien Shells Out $300M For Israeli Medical Device Maker
- Novartis Bone Drug Action Doomed By Statute Of Limitations
- Eisai Says Sanofi Misled Court In Feud Over Deposition Docs
- Obama Admin Floats Proposals On Contraception Rules
- Federal Plan To Share Health Insurance Risk Is Released
- Baxter Scores $24M Judgment In Fresenius Patent Suit
- GAO Denies TrailBlazer's $442M Medicare Bid Protest
- Schwarzenegger's Medicare Rule Opt-Out For Anesthetists OK'd
- Rising Star: Zuckerman's Marcos Hasbun
- DC Circ. Revives Cardinal Shipping Ban In Oxycodone Fight
- High Court Vows Same-Day Audio Of Health Care Debate
- Panel Recommends Standardized Medicare Treatment Fees
- Sens. Push For Stalled FDA Rule On Device ID System
- Genzyme Targets InvaGen Over Kidney Treatment Generics
- Learning From Blue Cross Data Breach Settlement
- Jury Rules In Favor Of Carl Zeiss In Lens Patent Suit
- Synthes, Stryker Settle Trade Secrets Suit Over Sales Reps
- Case Study: Bristol-Myers V. Kappos
- Sanofi Acquires Pluromed To Commercialize Surgical Gel
- Impax Can't Shake Injunction On Generic Amrix
- Bipartisanship Breaks Down Behind Medicare Board Repeal
- Intervening Rights Require Text Changes, Fed. Circ. Says
- GSK Strikes $613M Deal With Omega For OTC Brands, Plant
- NYC, Rudin Reach Deal On Greenwich Village Mixed-Use Project
- Sanofi Asks Fed. Circ. To Upset Dr. Reddy's Allegra Patent Win
- CBO Says 5M May Lose Employer Coverage Under Health Law
- CVS Caremark Says No Wrongdoing Alleged In FCA Suit
- Shire Inks $325M Deal For Blood Disorder Drug Co.
- Guidant Can't Kill $726M FCA Suit Over Implant Claims
- Biotech Co. Sues Sandoz Over Remodulin Generic
- Shire Pulls US Drug Application, Blames FDA Delay
- Albemarle Loses Bid To Toss EPA Clean Air Act Suit
- Trends In White Collar Crime Investigations, Prosecutions
- Judge Combines 2 Suits Over Egg Donor Price Caps
- Professor Seeks FDA Probe Into Stem Cell Cos.' Practices
- 3rd Circ. Grants Arbitration In Tenet Meal Break Case
- DaVita Unit Can't Sidestep Ex-Nurse's Medicaid Fraud Suit
- Faruqi Firm Won't Get Lead Role In Roche Takeover Action
- Microsoft Revises Privacy Policy To Reflect Targeted Health Ads
- DC Circ. Lifts CVS Pharmacies' Prescription Sale Ban
- Roche Loses Bid To Block Generic Boniva
- Teva Gets FDA Green Light For 1st Lexapro Generic
- 9th Circ. Seeks Amicus Briefs On Medicare Claim Appeals
- Hospital Asks 3rd Circ. To Drop Judge In Antitrust Row
- HHS Loosens Oversight Of Medicare Equipment Suppliers
- Judge Slashes Ex-Omeros Exec's FCA Suit Over NIH Grants
- Forest Labs Starts Patent Battle Over Beta-Blocker
- Pay For Delay, There For The Taking?
- The Uncertainty Of Medicaid Entitlement Enforcement
- Patient Broker Admits Role In $205M Medicare Bribery Scam
- UK Medical Journal Invokes Anti-SLAPP Law In Libel Suit
- FTC Seeks More Info From Roche On $6B Illumina Takeover
- Pfizer Won't Get To Trim BYU's Bextra-Celebrex Suit
- Boston Scientific Award Upped To $42M In Cordis Stent IP War
- DOJ Defends FOIA Response In Kagan Health Care Fight
- Tenn. Blue Cross To Hand Over $1.5M For Patient Data Breach
- University of Miami Says Medicaid FCA Suit Lacks Facts
- Roche Unit Loses In Arbitration Over Merger Of Medical Cos.
- Precision BioSciences Expands Patent War Against Cellectis
- DC Circ. Foils Bid To Ban Mercury-Containing Vaccines
- Texas Hospital Dodges $30M FCA Suit Over Drug Supplies
- Some Warner Chilcott Birth Control May Not Work, FDA Warns
- Cover Your Tail: Post-Termination Options For Docs
- AstraZeneca Sues FDA Over Generic Seroquel Labels
- Express Scripts, Medco Delay Deal Pending FTC Review
- Medtronic Investors Sue Over $3B Inflated Stock Buyback
- Injured Wal-Mart Workers Seek Approval Of $8M Settlement
- Sandoz, Others Escape Faulty Painkiller Patch Case
- HHS Issues Final, Flexible State Insurance Exchange Rule
- Japanese Health Giant Snaps Up Device Maker For $2.2B
- Bayer Must Allow Cancer Generic In India, Court Rules
- FDA To Review TV Drug Ads Before Broadcast
- Report Criticizes Cost Monitoring In DOD Health Program
- Judge Says Co. Can 'Fill Gap' To Trigger Excess Policy
- Calif. County Wants Claims Cut Loose From Plasma MDL
- GSK Skirts FCA Suit Over Physician Kickback Program
- J&J Unit's Stelara Infringes Abbott Patents, Judge Rules
- FTC Asks Pharm Groups How To Fix $29B Express Scripts Deal
- Why Communications Is Key To Merger And Lateral Success
- Drugmaker Bryan Corp. Sues Supplier Over Ingredient Quality
- FDA Moves To Improve Tracking Of Drug Safety Issues
- FDA Approves Third Silicone Gel Breast Implant
- FDA Rebuffs AstraZeneca's Bid To Delay Generic Seroquel
- Biotech Industry Sees Dollar Signs In Jobs Bill
- Lilly, Zydus Settle ADHD Generic Infringement Case
- Calif. Mulls Easing Abortion Law As Other States Set Limits
- Sens. Probe Role Of Rite Aid Wellness Ambassadors
- Azur, Avanir Push To Arbitrate $35M FazaClo Feud
- Maximus, Insurer Drop Claims Over $78M Texas Settlement
- Health Care Is Undergoing Major Surgery In 2012
- Ex-Partner Goes After Troutman In $520M Malpractice Suit
- GSK Seeks High Court Input On IP Safe-Harbor Rule
- Latham & Watkins Reps Boston Scientific In $1.3B Deal
- Tobacco Ads Spurred Minors To Smoke, Surgeon General Says
- Add-Ons To Drug User Fee Law Hit FDA Opposition
- Limbaugh Backlash Sparks Fight Over Concentra Name
- Blue Cross Cites Split Circuits In Antitrust Immunity Appeal
- Chadbourne Atty Can't Stop Apartment Roof Garden
- Health Groups Fight Delay Of Clear Insurance Explanations
- Final Committee OKs Nixing Health Law's Medicare Board
- Ill. Agencies Faulted Over $7B In Health Care Contracts
- Tackling 'Pay-For-Delay' In Calif. Supreme Court
- The Interplay Between FDA Approval And Discovery Rule
- AstraZeneca Sues Mylan Over Nexium Patents
- Judge Blocks Rival Botox Drug In Trade Secrets Trial
- Google Ordered To Dispense Canadian Pharmacy Ad Docs
- Investor Fights Illumina's Poison Pill Against Roche Bid
- Takeda Hid Diabetes Drug's Heart Risks, Ex-Reviewer Says
- Senate OKs Bill To Beef Up Counterfeit Drug Penalties
- NY Regulator Blasts Out-Of-Network Health Care Costs
- Pfizer, Others Sued By Health Plans Over Copay Coupons
- Medicare Pushes To Recruit Seniors In Fraud Fight
- Amgen Seeks High Court Review Of Investor Class Cert.
- Sens. Push Sebelius To Protect Medical Research Funds
- Boiron To Pay Up To $12M To End False Advertising Suits
- Enzo Targets Abbott, Others Over DNA Testing Patents
- The Dark Side Of The Power Wheelchair Revolution
- Tort Wars: The Calif. Legislature Strikes Back
- Espada Tax Charges Filed In Wrong District, Judge Says
- GOP Lawmakers Scrutinize Low-Cost Drug Program
- 11th Circ. Limits Contribution Claims Under CERCLA
- J&J Unit In Hot Seat Over Pfizer ThermaCare IP
- Lawmakers Demand Info On Agencies' Email Monitoring Rules
- Lorillard Owes $41M To Lung Cancer Widow, Jury Finds
- Medtronic Had Burden In Device IP Suit, Fed Circ. Told
- Reed Smith Guides Domain In $760M Venture With Rusnano
- Coventry, Policyholders Agree To $3.3M Deal Over Copays
- AeroShot Caffeine Inhaler Scrutinized By FDA
- Repeal Of Medicare Cost Board Zipping Along In House
- FDA Finds Multiple Quality Violations At Synthes Plant
- Texas Doc Denied Bail In Record Medicare Fraud Case
- Avanir Targets Watson In Suit Over Nuedexta Patents
- Premerger Plans Aren't Anti-Competitive: Calif. Court
- DC Circ. Lifts Shipping Ban On Cardinal Health
- Mensing Shields Generics Makers In Sprawling Darvocet MDL
- Immucor To Pay $22M To Stanch Blood Test Antitrust Action
- Doctors Bash Plan To Fight Rx Abuse By Denying Claims
- Zingers Fly As House Closes In On Medicare Board Repeal
- Ex-FDA Chemist Gets 5 Years For Insider Trading
- FDA Rejects Merck's Combo Cholesterol Drug For Now
- Judge Won't Halt NH Medicaid Cut Fight, Citing High Court
- Health Info Services Co. Jobson Gets OK On Prepack Ch. 11
- Novo Nordisk Faces $70M Sales Rep OT Action
- UK Biotech Co. Abcam Expands With $170M Epitomics Buy
- Calif. Council Merges 13 Cases Over Sutter Health Data Leak
- DaVita Can't Escape FCA Suit Over Kidney Med Charges
- NH Wins 1st Medicaid Boost For In-Home Senior Care
- Sunovion Knocks Out 5 Patents In Mylan's Brovana Suit
- Invisalign Maker Tells ITC Rival's Imports Infringe Patents
- Grassley Seeks Medicaid Managed Care Rate Setting Info
- Millennium Labs Wants Rival's Attys Booted For Misconduct
- Merck Action Didn't Stop The Clock, Va. High Court Says
- Law360 Life Sciences Editorial Advisory Board
- Law360 Health Editorial Advisory Board
- GOP Attacks $111B Jump In Health Reform Law Spending
- Perkins Coie Nabs Health Team For New Practice Group
- GSK Shakes EU Scrutiny In Generics Delay Probe
- How CMS Plans To Recoup Medicare, Medicaid Overpayments
- Odyssey Strikes $25M Deal Over Medicare Fraud Claims
- New NY Bankruptcy Chief Chides Attys In St. Vincent Case
- New Drug Co. Ethics Rules Focus On Doctor Relations
- Jury Sides With Pfizer Unit In Prempro Breast Cancer Case
- Relief Offer Annuls Nurse's Action, Genesis Tells High Court
- HHS' Sebelius Under Fire Over Contraception Rules
- FDA Warns Of 2 Hazardous Chemicals Used In Drugs
- Pfizer, Apotex End Patent Fight Over Generic Lipitor
- FDA Delays Approval Of Pfizer-BMS Anti-Clotting Drug
- Reglan Failure-To-Warn Suit Brought To Supreme Court
- Cardinal Health Painkiller Shipment Suspension Upheld
- Investor Objections Can't Halt Amgen's $1.2B Micromet Buy
- Senate Blocks Religious Exemption To Health Coverage
- Pfizer Asks High Court To Scrap Novartis Hemophilia Patents
- EU Kills Generics Delay Probe Of AstraZeneca, Nycomed
- NYC Hospital Pays $13M For Medicare Turbocharging